Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons

Journal of Infectious Diseases

Volumn 180, Issue 3, 1999, Pages 871-875

  Mazzoli, Sandra ^a   Lopalco, Lucia ^b   Salvi, Alessandra ^a   Trabattoni, Daria ^c   Lo Caputo, Sergio ^a   Semplici, Francesca ^a   Biasin, Mara ^c   Blé, Claudio ^a   Cosma, Antonio ^b   Pastori, Claudia ^b   Meacci, Francesca ^a   Mazzotta, Francesco ^a   Villa, Maria Luisa ^c   Siccardi, Antonio G ^b   Clerici, Mario ^c  

^a SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS RNA;

ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; MONONUCLEAR CELL; PRIORITY JOURNAL; SEROCONVERSION; SEXUAL TRANSMISSION; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS RESISTANCE; VIRUS TITRATION;

FEMALE; HIV ANTIBODIES; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; NEUTRALIZATION TESTS; RISK FACTORS; RISK-TAKING; SEXUAL BEHAVIOR;

EID: 0040272195     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314934     Document Type: Article

References (16)

1. 1. Rowland-Jones SL, McMichael A, Immune responses in HIV-exposed seronegatives: have they repelled the virus? Curr Opin Immunol 1995;7: 448-55.
2. 2. Shearer GM, Clerici M. Protective immunity against HIV infection: has nature done the experiment for us? Immunol Today 1996;17:21-4.
3. 3. Cocchi F, Devico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1a, MIP-1b as the major HIV-suppressive factors produced by CD8 T cells. Science 1995;270:1811-5.
4. 4. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-77.
5. 5. Lehner T, Wang Y, Cranage M, et al. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nature Med 1996;2:767-75.
6. 6. Bukawa H, Sekigawa KI, Hamajima K, et al. Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate. Nature Med 1995;1:681-5.
7. 7. Mazzoli S, Trabattoni D, Lo Caputo S, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nature Med 1997;3:1250-7.
8. 8. Arends JW, Groniowski MM, de Koning Gans HJ, Bosman FT. Immunohistochemical study of the distribution of secretory component IgA in normal and diseased uterine mucosa. Int J Gynecol Pathol 1983;2:171-81.
9. 9. Cao YZ, Friedman-Kien AE, Chuba VJ, Mirabile M, Hosein R. IgG antibodies to HIV-1 in urine of HIV-seropositive individuals. Lancet 1988;1: 831-8.
10. 10. Zolla-Pazner S, Sharpe S. A resting cell assay for improved detection of antibody-mediated neutralization of HIV type 1 primary isolates. AIDS Res Hum Retroviruses 1995;11:1449-58.
11. 11. Ping W, Miller B, Gallarda J. Early detection of IgM antibodies to HIV-1 by recombinant antigen enzyme immunoassay [abstract We.C. 3184]. In: Program and abstracts: XI International Conference on AIDS (Vancouver, Canada). Vancouver: XI International Conference on AIDS Society, 1996.
12. 12. Salk J, Bretscher PA, Salk PL, Clerici M, Shearer GM. A strategy for prophylactic vaccination against HIV. Science 1993;260:1270-2.
13. 13. Ravetch JV, Kinet JP. Fe receptors. Annu Rev Immunol 1991;9:457-92.
14. 14. Tenner-Racz K, Racz PP, Schmidt H, et al. Localization of HIV on follicular dendritic cells. AIDS 1988;2:299-309.
15. 15. Heath SL, Grant J, Tew JG, Szakal AK, Burton GF. Follicular dendritic cells and HIV infectivity. Nature 1995;377:740-4.
16. 16. Stoiber H, Clivio A, Dierich MP. Role of complement in HIV infection. Annu Rev Immunol 1997;15:649-74.